Sterling Investment Advisors, Ltd. - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 47 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2018. The put-call ratio across all filers is 4.69 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sterling Investment Advisors, Ltd. ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2022$1,000
-66.7%
2,5000.0%0.00%
-100.0%
Q1 2022$3,0000.0%2,5000.0%0.00%0.0%
Q4 2021$3,000
-40.0%
2,5000.0%0.00%0.0%
Q3 2021$5,000
+25.0%
2,5000.0%0.00%0.0%
Q2 2021$4,000
-33.3%
2,5000.0%0.00%
-50.0%
Q1 2021$6,0000.0%2,5000.0%0.00%0.0%
Q4 2020$6,0000.0%2,5000.0%0.00%0.0%
Q3 2020$6,000
-25.0%
2,5000.0%0.00%
-33.3%
Q2 2020$8,000
+60.0%
2,5000.0%0.00%0.0%
Q1 2020$5,0000.0%2,5000.0%0.00%
+50.0%
Q4 2019$5,0000.0%2,5000.0%0.00%
-33.3%
Q3 2019$5,000
+25.0%
2,5000.0%0.00%
+50.0%
Q2 2019$4,000
-20.0%
2,5000.0%0.00%
-33.3%
Q1 2019$5,000
+66.7%
2,5000.0%0.00%
+50.0%
Q4 2018$3,000
-50.0%
2,5000.0%0.00%
-33.3%
Q3 2018$6,000
-25.0%
2,5000.0%0.00%
-40.0%
Q2 2018$8,000
-27.3%
2,5000.0%0.01%
-28.6%
Q1 2018$11,0002,5000.01%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q1 2018
NameSharesValueWeighting ↓
WEDBUSH SECURITIES INC 277,177$915,0000.11%
WEBSTER BANK, N. A. 50,000$165,0000.02%
Brown Advisory Securities, LLC 28,000$92,0000.02%
SIMPLEX TRADING, LLC 50,804$167,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$83,0000.00%
GROUP ONE TRADING, L.P. 89,372$295,0000.00%
Squarepoint Ops LLC 10,194$34,0000.00%
Tower Research Capital LLC (TRC) 1,851$6,0000.00%
WOLVERINE TRADING, LLC 58,500$193,0000.00%
WOLVERINE TRADING, LLC 61,690$204,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders